Market Tracker

10/24 6:05pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

17.33
Data as of Oct 24
 +2.79 / +19.19%
Today’s Change
5.40
Today|||52-Week Range
18.07
+134.51%
Year-to-Date

Today’s Trading

Previous close14.54
Today’s open14.40
Day’s range14.10 - 18.07
Volume5,534,585
Average volume (3 months)691,999
Market cap$752.0M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-106.46%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratioNM
Price/Sales14.53
Price/Book7.75

Competitors

 Today’s
change
Today’s
% change
ASPXAuspex Pharmaceutica...+0.42+1.56%
TTPHTetraphase Pharmaceu...+0.09+0.38%
RGENRepligen Corp+0.13+0.54%
INSMInsmed Inc-0.06-0.42%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 12, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts